SCHEMBL4878445

SCHEMBL4878445

CCCCc1c[nH]nc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 6/20 0.47
HCAR3 P49019 2/20 0.45
GABRP O00591 2/20 0.42
GABRD O14764 2/20 0.42
GABRA1 P14867 2/20 0.42
GABRB1 P18505 2/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
GABRA5 P31644 2/20 0.42
GABRA3 P34903 2/20 0.42
GABRA2 P47869 2/20 0.42
GABRB2 P47870 2/20 0.42
GABRA4 P48169 2/20 0.42
GABRE P78334 2/20 0.42
GABRA6 Q16445 2/20 0.42
GABRG1 Q8N1C3 2/20 0.42
GABRG3 Q99928 2/20 0.42
GABRQ Q9UN88 2/20 0.42
HAO1 Q9UJM8 1/20 0.39
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL948543 0.95 HCAR2 (0.46) HCAR2HCAR3HAO1TSHRPPARA
SCHEMBL11365602 0.93 HCAR2 (0.48) HCAR2HCAR3HAO1TSHRPPARA
SCHEMBL948133 0.89 HCAR2 (0.42) HCAR2HCAR3HAO1KDM4E
SCHEMBL28771084 0.85 GABRP (0.38) HCAR2HCAR3GABRPGABRDGABRA1
SCHEMBL591059 0.83 HCAR2 (0.44) HCAR2HCAR3GABRPGABRDGABRA1
SCHEMBL8584565 0.81 HCAR2 (0.40) HCAR2HCAR3MEN1ALDH1A1TSHR
SCHEMBL27432771 0.79 HCAR2 (0.33) HCAR2KDM4ELMNA
SCHEMBL951258 0.78 KDM4E (0.41) HCAR2HCAR3KDM4EMEN1ALDH1A1
SCHEMBL30420119 0.77 IKBKB (0.36) HCAR2
SCHEMBL3044296 0.76 HCAR2 (0.37) HCAR2KDM4EALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105247391-B Near infrared ray absorbing composition, near infrared ray cut-off filter and its manufacturing method and camera module and its manufacturing method 富士胶片株式会社 2018-06-12 CN disclosed
US-20080090836-A1 Pyrazole Compounds Useful In The Treatment Of Inflammation BIOLIPOX AB (SE) 2008-04-17 US disclosed
EP-1794130-A1 PYRAZOLE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATION Biolipox AB (SE) 2007-06-13 EP disclosed
WO-2006032852-A1 PYRAZOLE COMPOUNDS USEFUL UIN THE TREATMENT OF INFLAMMATION BIOLIPOX AB (SE) 2006-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090836-A1 Pyrazole Compounds Useful In The Treatment Of Inflammation ALOX15, ALOX15B, ALOX12 HCAR2 336/4885HCAR3 393/4885GABRP 2493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.